DUBLIN–(BUSINESS WIRE)–The “Global Anti-Thrombin III Testing Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
The anti-thrombin III testing market is poised to grow by $ 161.48 mn during 2022-2026, accelerating at a CAGR of 7.73%
This study identifies the presence of various blood clotting disorders as one of the prime reasons driving the anti-thrombin III testing market growth during the next few years. Also, rise in the geriatric population and prevalence of inherited anti-thrombin deficiency will lead to sizable demand in the market.
The market is driven by existence of tests related to anti-thrombin III, increase in the number of people with hypertension, and shift toward rapid diagnostics.
The report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The anti-thrombin III testing market analysis includes the end-user segment and geographic landscape.
The publisher’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-thrombin III testing market vendors.
Also, the anti-thrombin III testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
Key Topics Covered:
1 Executive Summary
- Market overview
2 Market Landscape
- Market ecosystem
3 Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021-2026
4 Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
5 Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals – Market size and forecast 2021-2026
- Laboratories – Market size and forecast 2021-2026
- Academic and research institutes – Market size and forecast 2021-2026
- Market opportunity by End-user
6 Customer Landscape
- Customer landscape overview
7 Geographic Landscape
- Geographic segmentation
- Geographic comparison
8 Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market trends
9 Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
- Industry risks
10 Vendor Analysis
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Biron Health Group Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Grifols Sa
- Invitae Corp.
- Merck Kgaa
- Meridian Bioscience Inc.
- Oy Medix Biochemica Ab
- Randox Laboratories Ltd.
- Scripps Laboratories Inc.
- Sekisui Diagnostics LLC
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Transasia Bio Medicals Ltd.
- Werfenlife Sa
For more information about this report visit https://www.researchandmarkets.com/r/uzdr2c
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
